Abstract: A control method and associated system provide for thermal management of cables within a structure of a wind turbine. An airflow is established through the structure, the airflow moving along and around the cables within the structure to remove heat generated in the cables via heat transfer from a core of the cables through a surrounding insulation layer of the cables. Ambient temperature and a volumetric flow rate of the airflow adjacent the cables is measure. Based on the flow rate and the ambient temperature, a threshold current capacity limit for the cables is determined and used as a control factor for increasing power production of the wind turbine within thermal limits of the cables.

Abstract: A door frame fitness equipment, comprising two fixed frames set side by side, one end of which is bent upward and fixedly mounted with a fixed hanging plate, which is hung on upper support surface of door frame; a center crossbar, set perpendicularly to two fixed frames, said center crossbar is mounted on upper end or lower end of two fixed frames, and both sides of center crossbar extend outwardly towards two sides of fixed frames; two center connectors, respectively used to connect two fixed frames and center crossbar, two fixed frames and center crossbar pass through two center connectors respectively and are fixedly connected with said center connectors. The disclosure adopts principle of leverage to lock whole fitness equipment on the door frame at both sides, making fixing more solid and stable, and it can be equipped with different accessories to realize expansion of functions.

Abstract: Disclosed is a multi-layer low-profile four-arm spiral antenna, including a metal grounding plate, and a top surface of the metal grounding plate is fixedly connected with three layers of cylindrical dielectric substrates; the three layers of dielectric substrates are coaxially arranged, and the three layers of dielectric substrates are coaxially arranged with the metal grounding plate, and a gap is set between two adjacent layers of dielectric substrates; four spiral metal strips with a same rotation direction are respectively arranged on each layer of dielectric substrate, the four spiral metal strips on each layer of dielectric substrate form spiral radial arms, and a phase difference of the four spiral metal strips on each layer of dielectric substrate is 90°; the corresponding spiral metal strips on the two adjacent layers of dielectric substrates are connected by connecting bridges, the connecting bridges are arranged in the gap.

Abstract: The present invention relates to an apparatus for automatically charging a vehicle in an unmanned intelligent parking device, which is applied to various unmanned parking devices in need of a charging function. The apparatus includes a carrier fora parking device, the carrier being provided with a lifting component and a traveling component, where the apparatus further includes a charging docking apparatus, a charging adapter, a storage location charging fixing seat and a storage location power pickup apparatus, the storage location charging fixing seat is arranged in a parking space of the parking device, the carrier is provided with the charging docking apparatus, the storage location power pickup apparatus is mounted on the storage location charging fixing seat, and the charging adapter is switched to the storage location charging fixing seat through the charging docking apparatus and electrically connected to the storage location power pickup apparatus.

Abstract: The present disclosure is directed to a cable securement assembly for protecting cables and/or cable bundles within a wind turbine. The cable securement assembly includes a cable spacer having an inner surface and an outer surface separated by a thickness and one or more fastening components. The inner surface defines an open center configured to receive the plurality of cables therein. The inner surface defines a plurality of cable locations defined by one or more through holes configured through the thickness. The one or more fastening components are configured to secure one or more of the plurality of cables at each cable location via the through holes.

Abstract: The present disclosure is directed to a cable securement assembly for protecting cables and/or cable bundles within a wind turbine. The cable securement assembly includes a cable spacer having an inner surface and an outer surface separated by a thickness and one or more fastening components. The inner surface defines an open center configured to receive the plurality of cables therein. The inner surface defines a plurality of cable locations defined by one or more through holes configured through the thickness. The one or more fastening components are configured to secure one or more of the plurality of cables at each cable location via the through holes.

Abstract: A method for treating a patient suffering from disorders and deficits of the central nervous system associated with diabetes, associated with aging and neurodegeneration, comprising attention deficit disorder in general, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease (AD), mild cognitive impairment, senile dementia, AIDS dementia, neurodegeneration, depression, and schizophrenia, comprising administering to a patient in need of such treatment an effective amount of a selective inhibitor of the 11-?-hydroxysteroid dehydrogenase Type 1 enzyme activity.

Abstract: The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.

Abstract: The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.

Abstract: The present invention relates to inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.

Abstract: A method for treating a patient suffering from disorders and deficits of the central nervous system associated with diabetes, associated with aging and neurodegeneration, comprising attention deficit disorder in general, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease (AD), mild cognitive impairment, senile dementia, AIDS dementia, neurodegeneration, depression, and schizophrenia, comprising administering to a patient in need of such treatment an effective amount of a selective inhibitor of the 11-?-hydroxysteroid dehydrogenase Type 1 enzyme activity.

Abstract: The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.

Abstract: The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.

Abstract: A method for treating a patient suffering from disorders and deficits of the central nervous system associated with diabetes, associated with aging and neurodegeneration, comprising attention deficit disorder in general, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease (AD), mild cognitive impairment, senile dementia, AIDS dementia, neurodegeneration, depression, and schizophrenia, comprising administering to a patient in need of such treatment an effective amount of a selective inhibitor of the 11-?-hydroxysteroid dehydrogenase Type 1 enzyme activity.

Abstract: The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.